U.S. Hot Stocks: Hot Stocks to Watch

Among the companies with shares expected to actively trade in Thursday's session are Wal-Mart Stores Inc. (WMT), Kohl's Corp. (KSS) and Weyerhaeuser Co. (WY).

Wal-Mart slashed its earnings guidance for the year, as the retail giant posted yet another decline in quarterly traffic and flat same-store sales. Shares fell slightly to $74 in premarket trading.

Kohl's said fiscal second-quarter earnings improved slightly as lower expenses masked a decline in sales for the department-store chain. Shares rose 2.5% to $56.50 premarket.

Weyerhaeuser Co. (WY) raised its quarterly dividend 32% and unveiled a $700 million share-buyback program as the company looks to continue reaping the benefits from a renewed focus on its core wood-products business. Shares gained 2.2% to $33.05 premarket.

Red Robin Gourmet Burgers Inc. (RRGB) said second-quarter earnings fell amid a jump in food-and-beverage costs, while same-store sales rose 1.2%. Shares sank 21.7% to $50.57 premarket.

Advance Auto Parts Inc. (AAP) said its second-quarter profit climbed on a 51.5% rise in sales as the auto-parts retailer's top- and bottom-lines remain bolstered by the acquisition of General Parts International Inc. Shares advanced 4.5% to $128.50 premarket.

T-Mobile US Inc.'s (TMUS) chief financial officer on Wednesday called a $15 billion takeover proposal from French wireless company Iliad SA (ILD.FR, ILIAY) "inadequate," but hinted it may be open to a higher offer. Shares edged up to $29.27 premarket.

Cisco Systems Inc. (CSCO) on Wednesday said it will cut about 6,000 jobs after reporting a quarter of little sales growth. Shares dropped slightly to $25.09 premarket.

Noodles & Co. (NDLS) on Wednesday said second-quarter results were below its expectations and lowered its outlook for the full year. Shares tumbled 21.1% to $19.90 premarket.

Supernus Pharmaceuticals Inc. (SUPN) said the U.S. Food and Drug Administration granted fast track designation for the specialty pharmaceutical company's attention deficit hyperactivity disorder treatment. Shares were up 4.4% to $9.80 premarket.

Keurig Green Mountain Inc. (GMCR) said it would increase prices by up to 9% on all portion packs for its popular Keurig brewing systems, citing risings costs of green coffee and cocoa.

 
   Watchlist: 
 

Allergan Inc. (AGN) has bought global rights to Taris Holdings LLC's lead program for $67.5 million in cash upfront and about $225 million in commercial milestone payments, the companies said Wednesday.

Amgen Inc. (AMGN) and its subsidiary Onyx Pharmaceuticals said on Wednesday their Kyprolis cancer drug failed to meet its primary endpoint of improving overall survival for patients with relapsed and advanced refractory multiple myeloma in a late-stage clinical trial.

NetEase Inc.'s (NTES, K3MD.SG) second-quarter profit rose nearly 10% as the Chinese Internet portal reported sustained revenue growth from online games and advertising, which benefited from the FIFA World Cup.

Re/Max Holdings Inc. (RMAX) reported better-than-expected second-quarter revenue as the brokerage franchiser continued to expand its pool of agents.

Tekmira Pharmaceuticals Corp. (TKMR) on Wednesday said it is looking into ways its experimental Ebola treatment might be used to combat a serious outbreak in West Africa, even if the drug hasn't been formally cleared by the various regulatory agencies.

Write to Tom Rojas at [e-mail] and Maria Armental at [e-mail]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires